Lydon Nicholas

Number of records: 25
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
14-Jun-24 5:34 PM
View: 
Blueprint Medicines Corp (BPMC) 12-Jun-24Grant 2,242----4%
55.78K to 58.03K
23-Jun-23 7:02 PM
View: 
Blueprint Medicines Corp (BPMC) 21-Jun-23Grant 2,600----5%
53.18K to 55.78K
30-Jun-22 9:56 PM
View: 
Blueprint Medicines Corp (BPMC) 21-Jun-22Grant 2,600----5%
50.58K to 53.18K
25-May-22 4:05 PM
View: 
Blueprint Medicines Corp (BPMC) 23-May-22Option Exercise 10,909$19.53$213,053.0027%
39.67K to 50.58K
04-Jun-21 4:14 PM
View: 
Blueprint Medicines Corp (BPMC) 02-Jun-21Grant 2,250----6%
37.42K to 39.67K
05-Oct-20 4:17 PM
View: 
Blueprint Medicines Corp (BPMC) 01-Oct-20Market Sale (Planned) 9,815$93.08$913,595.00(21%)
47.24K to 37.42K
(4%)
21-Sep-20 4:21 PM
View: 
Blueprint Medicines Corp (BPMC) 17-Sep-20Market Sale (Planned) 500$80.00$40,000.00(1%)
47.74K to 47.24K
(21%)
08-Jul-20 4:25 PM
View: 
Blueprint Medicines Corp (BPMC) 06-Jul-20Market Sale (Planned) 26,007$80.45$2,092,350.00(35%)
73.75K to 47.74K
(20%)
06-Jul-20 6:30 PM
View: 
Blueprint Medicines Corp (BPMC) 02-Jul-20Market Sale (Planned) 2,825$80.13$226,367.00(4%)
76.57K to 73.75K
(20%)
06-Jul-20 6:30 PM
View: 
Blueprint Medicines Corp (BPMC) 01-Jul-20Market Sale (Planned) 1,300$80.21$104,273.00(2%)
77.87K to 76.57K
(20%)
26-Jun-20 4:08 PM
View: 
Blueprint Medicines Corp (BPMC) 24-Jun-20Grant 2,250----3%
75.62K to 77.87K
25-Jun-20 4:10 PM
View: 
Blueprint Medicines Corp (BPMC) 23-Jun-20Market Sale (Planned) 400$80.00$32,000.00(< 1%)
76.02K to 75.62K
(21%)
23-Jun-20 4:13 PM
View: 
Blueprint Medicines Corp (BPMC) 22-Jun-20Market Option Sale (Planned) 1,312$80.29$105,340.00(1%)
89.04K to 87.73K
(20%)
23-Jun-20 4:13 PM
View: 
Blueprint Medicines Corp (BPMC) 22-Jun-20Market Sale (Planned) 11,705$80.29$939,794.00(13%)
87.73K to 76.02K
(20%)
23-Jun-20 4:13 PM
View: 
Blueprint Medicines Corp (BPMC) 19-Jun-20Option Exercise 1,312----1%
87.73K to 89.04K
19-May-20 4:31 PM
View: 
Blueprint Medicines Corp (BPMC) 15-May-20Gift 20,000----(19%)
107.73K to 87.73K
21-Aug-19 4:18 PM
View: 
Blueprint Medicines Corp (BPMC) 19-Aug-19Gift 20,000----(16%)
127.73K to 107.73K
17-Jun-19 5:11 PM
View: 
Blueprint Medicines Corp (BPMC) 13-Jun-19Market Sale (Planned) 25,000$90.36$2,259,000.00(16%)
152.73K to 127.73K
(7%)
14-Jun-19 6:00 PM
View: 
Blueprint Medicines Corp (BPMC) 12-Jun-19Market Sale (Planned) 25,000$84.77$2,119,160.00(14%)
177.73K to 152.73K
(14%)
18-Apr-18 4:46 PM
View: 
Anaptysbio, Inc (ANAB) 16-Apr-18Market Sale (Planned) 33,000$86.88$2,866,910.00(11%)
304.11K to 271.11K
59%
02-Mar-18 5:15 PM
View: 
Blueprint Medicines Corp (BPMC) 28-Feb-18Market Sale (Planned) 25,000$87.89$2,197,360.00(12%)
202.73K to 177.73K
(10%)
20-Feb-18 4:08 PM
View: 
Anaptysbio, Inc (ANAB) 15-Feb-18Option Exercise 16,483$4.55$74,997.706%
287.62K to 304.11K
16-Mar-17 5:37 PM
View: 
Blueprint Medicines Corp (BPMC) 14-Mar-17Market Sale (Planned) 70,000$40.05$2,803,720.00(26%)
272.73K to 202.73K
(141%)
31-Jan-17 4:49 PM
View: 
Anaptysbio, Inc (ANAB) 31-Jan-17Conversion 203,625----302%
67.33K to 270.96K
31-Jan-17 4:49 PM
View: 
Anaptysbio, Inc (ANAB) 31-Jan-17Private Purchase 16,666$15.00$249,990.006%
270.96K to 287.62K